Vexev raised $6 million to pursue FDA clearance, scale manufacturing, and commercialize its autonomous vascular imaging platform in the United States.
- Amount
- $6M
- Announced
- 6 August 2026
- Investors
- Blackbird Ventures, Neotribe Ventures, Startmate, Horizon, TreeArc Investment Group, TEN13, Bioshore Ventures, Alumni Ventures
- Use of funds
- Funding will support regulatory activities, manufacturing scale-up and commercialization.
- Total raised
- $19M to date
- Checked
- Announced by the company